Science Researcher Update

Re-Entering Antibacterial Drug Development Summit

Written by Stela BCI | Dec 15, 2015 2:58:54 PM

 

Conference - Boston, MA, United States

 

According to the Centers for Disease Control and Prevention, antibiotic-resistant infections are associated with an additional 23,000 deaths and 2 million illnesses in the United States each year. The estimated annual impact of antibiotic-resistant infections on the national economy is $20 billion in excess direct health care costs, and as much as $35 billion in lost productivity from hospitalizations and sick days. By holding the Re-Entering Antibacterial Drug Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to revive antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders, who are shaping the current state of antibacterial discovery and development.

Sponsoring Institutions: Cambridge Healthtech Institute

For more information, please visit: http://www.healthtech.com/Antibacterial-Drug-Development/

 

November 16-18, 2015

Hilton Boston Back Bay

Boston, MA 02210, United States

Contact: Marina Filshtinsky (chi@healthtech.com)
Contact: 7819725400

 

If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.